We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,470

China newsletter, Summer 2014 No. 27
  • Greenberg Traurig LLP
  • China
  • July 31 2014

On February 20, 2014, the State Administration for Industry and Commerce published the Administrative Provisions on the Registration of the


UK Serious Fraud Office launches investigation into GlaxoSmithKline in relation to claims of foreign bribery
  • Squire Patton Boggs
  • China, United Kingdom
  • June 10 2014

The UK's Serious Fraud Office ("SFO") has launched a formal criminal investigation into GlaxoSmithKline (GSK) and its "commercial practices"


China unveils detailed rules to implement the core device regulation
  • Ropes & Gray LLP
  • China, USA
  • August 5 2014

The amended Regulation for the Supervision and Administration of Medical Devices (the "Regulation," also known as the State Council Order No. 650


Food, dietary supplement & cosmetics regulatory update, Issue 11
  • Jones Day
  • Canada, China, USA
  • August 8 2014

Last week, a divided federal appeals court ruled that FDA cannot be forced to ban antibiotics in food-producing healthy livestock. Thedecision comes


Door opens for 100 foreign ownership of Chinese hospitals on pilot basis
  • Frost Brown Todd LLC
  • China
  • September 17 2014

US health care businesses see China as a waiting market, ready for the introduction of world-class hospitals and care centers. China understandably


GSK China fined a record $492 million for bribery in China
  • Herbert Smith Freehills LLP
  • China
  • September 22 2014

In a landmark case, a Chinese court has fined GlaxoSmithKline's China subsidiary (GSK China) US$ 492 million dollars for bribing doctors and


Be global: employment law newsletter - November 2014
  • DLA Piper LLP
  • Australia, Belgium, Brazil, China, France, USA, Hong Kong, Italy, Qatar, Romania, Saudi Arabia, United Kingdom
  • November 21 2014

The UK Employment Appeal Tribunal recently handed down judgment in the closely watched appeals in a number of cases concerning the calculation of


China issues new regulations prohibiting commercial bribery in the health care industry
  • Reed Smith LLP
  • China
  • January 30 2014

In late December, China's National Health and Family Planning Commission ("NHFPC"), the successor organization to the Ministry of Health, issued two


Drug commodity name protection, a pitfall in the newly revised Trademark Law?
  • CMS Cameron McKenna
  • China
  • October 31 2013

One of the new provisions of the revised PRC Trademark Law, effective as of 1 May 2014, is the protection of the priority right of a trademark which


Expansion of wholly foreign invested hospitals
  • CMS, China
  • China
  • September 8 2014

Following the publication of a new circular by the National Health and Family Planning Commission and the Ministry of Commerce, foreign investors are